Technology and innovation: A brief history of Ojjaar (momelotinib) approved by the FDA, discovered in Melbourne
用户wEPMgFb_HJo8
24天前
43
10
已关闭
DOI:
文献链接:
其他信息:
C Burns
Chemistry in Australia, 2023
search.informit.org
On 15 September 2023, the US Food and Drug Administration (FDA) announced that momelotinib, an orally bioavailable JAK1/JAK2 kinase inhibitor (JAK1 and JAK2 being enzymes …